prison hierarchy Shortcuts comparing roc of several markers Admirable regional length
Novel inflammatory markers in the blood of patients with knee synovitis - Kun Gao, Yong Zhang, Shufen Sun, Baocheng Lin, Weidong Liu, Wenqiang Lai, Yihong Wu, Zhanpeng Lin, Yinglu Jiang, Yafei Cao,
A relationship between the incremental values of area under the ROC curve and of area under the precision-recall curve | Diagnostic and Prognostic Research | Full Text
A novel panel of microRNAs provides a sensitive and specific tool for the diagnosis of breast cancer
The Comparison of Different Coagulation Markers in Thrombosis Prediction in COVID-19 Pneumonia - ISTH Congress Abstracts
ROC curve analysis with multiple markers compared with a single marker.... | Download Scientific Diagram
How can I test the difference in area under ROC curve for two logistic regression models? | Stata FAQ
Centre-independent Detection of Non-small Cell Lung Cancer (NSCLC) by Means of Classification with Receiver Operating Characteristic (ROC)-based Data Transformation | Anticancer Research
Identification of COVID-19 prognostic markers and therapeutic targets through meta-analysis and validation of Omics data from nasopharyngeal samples - eBioMedicine
Comparison of the area under ROC curve (AUC) of three diagnostic models based upon 1: BMI; 2: BMI, GGT, TG, waist or 3: metabolic marker set.
Evaluation of Psoriasis Genetic Risk Based on Five Susceptibility Markers in a Population from Northern Poland | PLOS ONE
Selected serum cytokines and nitric oxide as potential multi-marker biosignature panels for Parkinson disease of varying durations: a case-control study | BMC Neurology | Full Text
CombiROC: an interactive web tool for selecting accurate marker combinations of omics data | Scientific Reports
Frontiers | Emerging Molecular Markers Towards Potential Diagnostic Panels for Lupus
CombiROC: an interactive web tool for selecting accurate marker combinations of omics data | Scientific Reports
Sensors | Free Full-Text | Designing a Simple Fiducial Marker for Localization in Spatial Scenes Using Neural Networks
A comparison of landmark methods and time-dependent ROC methods to evaluate the time-varying performance of prognostic markers for survival outcomes | Diagnostic and Prognostic Research | Full Text
Development of Serum Marker Models to Increase Diagnostic Accuracy of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: The New LINKI Algorithm Compared with Established Algorithms | PLOS ONE
What is a ROC Curve - How to Interpret ROC Curves - Displayr
Performance of prognostic markers in pediatric sepsis | Jornal de Pediatria
CombiROC: an interactive web tool for selecting accurate marker combinations of omics data | Scientific Reports
Utility of reticulocyte haemoglobin content and percentage hypochromic red cells as markers of iron deficiency anaemia among black CKD patients in South Africa | PLOS ONE
Cell-Free Circulating Plasma hTERT mRNA Is a Useful Marker for Prostate Cancer Diagnosis and Is Associated with Poor Prognosis Tumor Characteristics | PLOS ONE
View of The significance of C-reactive protein to albumin ratio in patients with decompensated cirrhosis | Annals of Gastroenterology
How many markers are needed to robustly determine a cell's type? - ScienceDirect
Urinary CXCL-10/IP-10 and MCP-1 as markers to assess activity of lupus nephritis - B Abujam, SS Cheekatla, A Aggarwal, 2013
The combination of cerebrospinal fluid procalcitonin, lactate, interleukin-8 and interleukin-10 concentrations for the diagnosis of postneurosurgical bacterial meningitis: A prospective study - Guojun Zhang, Chunjiao Yang, Xixiong Kang, Zhixian Gao ...
Create and compare ROC curves for any predictive model - The DO Loop
A comparison of landmark methods and time-dependent ROC methods to evaluate the time-varying performance of prognostic markers for survival outcomes | Diagnostic and Prognostic Research | Full Text
Combination of PCT, sNFI and dCHC for the diagnosis of ascites infection in cirrhotic patients | BMC Infectious Diseases | Full Text
Comparison of the Serum Tumor Markers S100 and Melanoma-inhibitory Activity (MIA) in the Monitoring of Patients with Metastatic Melanoma Receiving Vaccination Immunotherapy with Dendritic Cells | Anticancer Research